See more : iStar Inc. (STAR-PI) Income Statement Analysis – Financial Results
Complete financial analysis of Rajthanee Hospital Public Company Limited (RJH.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rajthanee Hospital Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Broadex Technologies Co., Ltd. (300548.SZ) Income Statement Analysis – Financial Results
- Samsung Engineering Co., Ltd. (028050.KS) Income Statement Analysis – Financial Results
- Public Joint Stock Company “ROSSETI Northern Caucasus” (MRKK.ME) Income Statement Analysis – Financial Results
- Mobile Global Esports Inc. (MGAM) Income Statement Analysis – Financial Results
- Wiseman Global Limited (WISM) Income Statement Analysis – Financial Results
Rajthanee Hospital Public Company Limited (RJH.BK)
About Rajthanee Hospital Public Company Limited
Rajthanee Hospital Public Company Limited, together with its subsidiaries, provides healthcare services in Thailand. The company offers medical, health improvement, rehabilitation, and medical prevention services for general and acute illness through general practice and specialty physicians. It also provides medical services in areas, such as medicine, surgery and orthopedics, pediatrics, obstetrics and gynecology, otolaryngology, ophthalmology, anesthesiology, radiology, and dentistry. The company operates emergency medicine and brain neurosurgery, heart, surgery, orthopedics, health check-up, radiology, diagnostic, ophthalmology, hemodialysis, sleep test, and dental centers. Rajthanee Hospital Public Company Limited was incorporated in 1990 and is headquartered in Phra Nakhon Si Ayutthaya, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.35B | 3.37B | 3.12B | 1.86B | 1.77B | 1.59B | 1.40B | 1.21B | 1.02B | 957.72M | 795.67M | 691.58M |
| Cost of Revenue | 1.62B | 1.85B | 1.68B | 1.26B | 1.21B | 1.10B | 985.67M | 876.62M | 801.68M | 722.31M | 525.06M | 465.01M |
| Gross Profit | 730.14M | 1.52B | 1.43B | 593.89M | 557.38M | 485.45M | 417.39M | 332.84M | 222.62M | 235.41M | 270.61M | 226.57M |
| Gross Profit Ratio | 31.10% | 45.10% | 45.98% | 32.01% | 31.48% | 30.58% | 29.75% | 27.52% | 21.73% | 24.58% | 34.01% | 32.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 222.43M | 244.95M | 183.46M | 163.27M | 188.19M | 182.44M | 153.19M | 137.37M | 110.08M | 93.83M | 65.91M | 58.41M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 222.43M | 244.95M | 183.46M | 163.27M | 188.19M | 182.44M | 153.19M | 137.37M | 110.08M | 93.83M | 65.91M | 58.41M |
| Other Expenses | -44.77M | 26.15M | 26.71M | 21.97M | 27.49M | 18.29M | 11.96M | 14.54M | 10.61M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 177.66M | 244.95M | 183.46M | 163.27M | 188.19M | 182.44M | 153.19M | 137.37M | 110.08M | 93.83M | 101.99M | 92.34M |
| Cost & Expenses | 1.80B | 2.09B | 1.87B | 1.42B | 1.40B | 1.28B | 1.14B | 1.01B | 911.76M | 816.14M | 627.05M | 557.35M |
| Interest Income | 0.00 | 9.44M | 379.90K | 930.02K | 4.76M | 5.33M | 9.21M | 3.35M | 0.00 | 26.11M | 9.79M | 9.31M |
| Interest Expense | 33.54M | 24.48M | 5.92M | 257.02K | 4.34M | 12.03M | 3.01M | 26.31M | 34.87M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 148.35M | 167.26M | 163.04M | 108.76M | 89.57M | 78.83M | 77.09M | 74.19M | 73.66M | 57.56M | 39.30M | 37.57M |
| EBITDA | 700.83M | 1.48B | 1.44B | 562.28M | 589.75M | 405.46M | 362.47M | 284.21M | 196.81M | 200.53M | 208.89M | 167.13M |
| EBITDA Ratio | 29.85% | 535.61% | 46.19% | 30.30% | 27.73% | 25.54% | 25.83% | 23.50% | 19.21% | 20.79% | 25.60% | 24.17% |
| Operating Income | 552.48M | 1.30B | 1.28B | 453.52M | 401.44M | 326.63M | 264.20M | 210.01M | 123.15M | 141.58M | 164.43M | 129.56M |
| Operating Income Ratio | 23.53% | 38.60% | 40.96% | 24.44% | 22.67% | 20.58% | 18.83% | 17.36% | 12.02% | 14.78% | 20.67% | 18.73% |
| Total Other Income/Expenses | -33.54M | -9.44M | -3.10M | 673.00K | 126.65M | 11.58M | 18.16M | -11.77M | -24.25M | -26.11M | -5.60M | -4.64M |
| Income Before Tax | 518.94M | 1.29B | 1.27B | 453.26M | 495.84M | 314.60M | 282.36M | 183.71M | 88.29M | 115.46M | 158.83M | 124.92M |
| Income Before Tax Ratio | 22.10% | 38.32% | 40.77% | 24.43% | 28.00% | 19.82% | 20.12% | 15.19% | 8.62% | 12.06% | 19.96% | 18.06% |
| Income Tax Expense | 103.24M | 255.80M | 254.92M | 39.64M | 99.30M | 56.44M | 26.45M | 28.77M | 24.52M | 30.64M | 4.81M | 5.93M |
| Net Income | 419.67M | 1.03B | 1.01B | 412.49M | 395.89M | 254.54M | 231.24M | 154.64M | 79.19M | 100.09M | 154.02M | 118.98M |
| Net Income Ratio | 17.87% | 30.58% | 32.46% | 22.23% | 22.36% | 16.03% | 16.48% | 12.79% | 7.73% | 10.45% | 19.36% | 17.20% |
| EPS | 1.40 | 3.44 | 3.37 | 1.38 | 1.32 | 0.85 | 0.77 | 0.62 | 0.35 | 0.44 | 0.68 | 0.53 |
| EPS Diluted | 1.40 | 3.44 | 3.37 | 1.38 | 1.32 | 0.85 | 0.77 | 0.62 | 0.35 | 0.44 | 0.68 | 0.53 |
| Weighted Avg Shares Out | 299.77M | 299.37M | 299.93M | 300.00M | 300.00M | 299.46M | 300.00M | 250.63M | 225.00M | 225.00M | 225.04M | 225.05M |
| Weighted Avg Shares Out (Dil) | 299.77M | 299.37M | 299.93M | 300.00M | 300.00M | 299.46M | 300.31M | 250.63M | 225.00M | 225.00M | 225.04M | 225.05M |
Source: https://incomestatements.info
Category: Stock Reports